Birchview Capital, LP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2022$566,000
-39.9%
50,000
-16.7%
0.41%
-32.9%
Q4 2021$941,000
-31.4%
60,000
-25.0%
0.61%
-34.9%
Q3 2021$1,371,000
-20.3%
80,0000.0%0.93%
-9.3%
Q2 2021$1,721,000
+43.2%
80,0000.0%1.03%
+44.1%
Q1 2021$1,202,000
+14.4%
80,0000.0%0.71%
+18.0%
Q4 2020$1,051,000
-32.0%
80,000
-50.0%
0.60%
+17.2%
Q3 2020$1,546,000
+69.0%
160,000
+100.0%
0.52%
-6.7%
Q2 2020$915,000
+10.4%
80,0000.0%0.55%
-24.8%
Q1 2020$829,000
-36.9%
80,0000.0%0.74%
-23.0%
Q4 2019$1,313,000
+23.6%
80,0000.0%0.95%
+34.7%
Q3 2019$1,062,000
-5.8%
80,0000.0%0.71%
+3.4%
Q2 2019$1,127,000
-23.4%
80,0000.0%0.68%
-25.7%
Q1 2019$1,472,000
-29.6%
80,0000.0%0.92%
-53.4%
Q4 2018$2,090,000
+3.5%
80,000
-9.1%
1.98%
+51.6%
Q3 2018$2,020,000
+20.5%
88,0000.0%1.30%
+14.5%
Q2 2018$1,676,000
+13.0%
88,0000.0%1.14%
+16.6%
Q1 2018$1,483,000
+10.8%
88,0000.0%0.98%
+24.6%
Q4 2017$1,338,000
+9.9%
88,000
+29.4%
0.78%
+24.6%
Q3 2017$1,217,000
+9.8%
68,0000.0%0.63%
+7.3%
Q2 2017$1,108,000
+46.6%
68,000
+25.9%
0.59%
+39.5%
Q1 2017$756,000
+115.4%
54,000
+145.5%
0.42%
+94.4%
Q4 2016$351,00022,0000.22%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders